Last reviewed · How we verify
NCT06253832
Conservative Management of Placenta Accreta Spectrum
NA trial testing conservative surgery for placenta accreta spectrum in Placenta Accreta in 36 participants. Completed in 30 January 2024.
17 August 2022
Quick facts
| Lead sponsor | Tunis University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 36 |
| Start date | 4 January 2020 |
| Primary completion | 17 August 2022 |
| Estimated completion | 30 January 2024 |
| Sites | 1 location across Tunisia |
Drugs / interventions tested
- conservative surgery for placenta accreta spectrum
- hysterectomy
- hysterectomy
Conditions studied
- Placenta Accreta — all drugs for Placenta Accreta →
- Post Partum Hemorrhage — all drugs for Post Partum Hemorrhage →
- Blood Loss Massive — all drugs for Blood Loss Massive →
Sponsor
Tunis University
Who can join
18 and older, female only, with Placenta Accreta or Post Partum Hemorrhage. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The resective-constructive surgery, detailed in prior research by Palacios-Jaraquemada JM, involves excising the placenta and its attachment on the myometrium, with modifications including the systematic use of a double JJ probe, omitting arterial ligation, and prioritizing careful dissection and reconstruction. A prospective single-center study conducted from January 4, 2020 to February 2, 2024, at the Tunisian maternity ward including cases of placenta accreta, increta and percreta. Data on the estimation of blood loss, complications, transfusions and intensive care admissions were recorded. Diagnosis of placenta accreta was based on imaging and histopathology. The blood loss calculation incorporates total blood volume and changes in hematocrit.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
New surgical technique for managing placenta accreta spectrum and pilot study of the "CMNT PAS" study.
Abouda HS, Aloui H, Azouz E, Marzouk SB, et al · · 2025 · cited 4× · PMID 39835285 · DOI 10.1016/j.xagr.2024.100430
Verify or expand the search:
- PubMed search for NCT06253832
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Placenta Accreta
Currently open trials in the same condition.
- NCT07283042 — Evaluation of Clinical Outcomes and Acceptability of an Anatomical Classification for Placenta Accreta Spectrum · recruiting
- NCT06465836 — Simplified Conservative Measures in Managing Morbidly Adherent Placenta in Beni-Suef University · NA · recruiting
- NCT06185894 — Single-step Placenta Accreta Resective Technique Tourniqueted vs Absence, Conservative Uterine Surgery · NA · recruiting
- NCT06833606 — Diagnosis and Outcomes of Placental Accretism · recruiting
- NCT05922397 — Placenta Accreta Spectrum Topographic Classification · recruiting
Other Tunis University trials
Trials by the same sponsor.
- NCT06655571 — What Technique for Caudal Block in Children: Conventional or Ultrasound-guided · NA · recruiting
- NCT06670846 — Management of Preoperative Anxiety in Children: Could a Lollipop Be the Solution? · NA · recruiting
- NCT06655168 — Orotracheal Intubation in Newborns: Videolaryngoscopy Vs Direct Laryngoscopy · NA · recruiting
- NCT07459088 — Central Venous Catheterization in Children: Jugulo-subclavian Venous Confluence Versus Internal Jugular Vein · NA · completed
- NCT07088432 — Intravenous Dexamethasone for Prolonging Sensory Block in Spinal Anesthesia · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06253832 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tunis University
- Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06253832.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing